Aurobindo completes $210M Lannett acquisition in US

30 Jun 2026via NSE FilingSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Aurobindo completes $210M Lannett acquisition in US — Aurobindo Pharma USA Inc., a wholly owned subsidiary, has completed the acquisition of Lannett Company Inc. for $210 million. This strategic move strengthens Aurobindo’s presence in the US generics market. The integration is expected to enhance product portfolio and revenue streams.

📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition

#Acquisition#USExpansion#Aurobindo

Stocks mentioned

AUROPHARMAAUROPHARMA

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →